Dr. Mary J. Xu
Overview
Dr. Mary J. Xu is a surgeon who specializes in head and neck cancers. Her technical expertise spans head and neck ablative surgery (using extreme heat or cold to destroy abnormal tissue), microvascular reconstruction (rebuilding the face and neck using blood vessels, bone and tissue from other parts of the patient's body), transoral robotic surgery (using computerized tools to access tumors through the mouth) and endocrine surgery (treating cancers of hormone-producing glands). Xu’s research focuses on improving care for head and neck cancers in resource-constrained health systems, both internationally and locally. Through the UCSF Global Cancer Program, she collaborates with health systems in Tanzania and Rwanda. She co-founded the Global Otolaryngology – Head and Neck Surgery Initiative, an international research collaborative. Xu earned her medical degree through the Harvard-MIT Program in Health Sciences and Technology. While in medical school, she spent a year at the Butaro Cancer Center in Rwanda studying health outcomes for patients with childhood cancer. She completed a residency in otolaryngology – head and neck surgery at UCSF, followed by a fellowship in head and neck oncology and microvascular reconstruction at the University of Pennsylvania. She completed a postdoctoral research fellowship in the National Clinician Scholars Program at UCSF.
Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Hearing Loss, Tonsillitis, Oral Squamous Cell Carcinoma, and Gastrostomy.
Dr. Xu is board certified in American Board Of Otolaryng/Plastic Surg Head-Neck, Otolaryngology. She is actively involved in clinical research, co-authoring 54 peer reviewed articles. Dr. Xu is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1825 Fourth St., Fifth Floor, San Francisco, CA 94158
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Head And Neck Surgery Cancer Program
Dr. Patrick Ha is chief of the UCSF Division of Head and Neck Surgical Oncology. His expertise in patient care covers the full scope of head and neck surgery, with a focus on thyroid and parathyroid surgery as well as endoscopic approaches to throat cancer surgery. Ha's research is currently focused on molecular changes that occur in adenoid cystic carcinoma of the salivary gland. Ha received an undergraduate degree in biology from Harvard University, graduating magna cum laude. He obtained his medical degree from Johns Hopkins School of Medicine, graduating with membership in the Alpha Omega Alpha Honor Medical Society. He then completed his residency training and a postdoctoral fellowship at the otolaryngology department of Johns Hopkins, along with advanced fellowship training in head and neck oncologic surgery. Ha serves on the editorial board of several medical journals, including Oral Oncology. He is the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professor in Head and Neck Cancer. Dr. Ha is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Salivary Gland Tumors, Tongue Cancer, Gastrostomy, and Laryngectomy. Dr. Ha is board certified in American Board Of Otolaryngology, Otolaryngology. Dr. Ha is currently accepting new patients.
Head And Neck Medical Oncology Program
Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma. Dr. Algazi is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Algazi is currently accepting new patients.
Head And Neck Surgery Cancer Program
Dr. Ivan H. El-Sayed is a head and neck cancer surgeon. He specializes in treating benign and malignant lesions of the salivary glands, paranasal sinuses and skull base. El-Sayed's research interests include examining the value of sentinel node biopsy (a procedure to check whether cancer has spread) for head and neck cancer. He also is investigating potential uses of lasers and nanoparticles for diagnosing and treating cancer. El-Sayed earned his medical degree and completed a residency in otolaryngology at Boston University School of Medicine. He completed a fellowship in head and neck oncology at UCSF. Dr. El is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Turbinectomy. Dr. El is board certified in American Board Of Otolaryngology, Otolaryngology. Dr. El is currently accepting new patients.
Frequently Asked Questions about Dr. Mary J. Xu
How do I make an appointment with Dr. Mary J. Xu?
You can book an appointment with Dr. Mary J. Xu by calling their office at 415-885-7528. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mary J. Xu a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mary J. Xu is classified as an Experienced expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mary J. Xu specialize in?
While Dr. Mary J. Xu is a Otolaryngology, they have specific expertise in Head and Neck Squamous Cell Carcinoma (HNSCC), Hearing Loss, and Tonsillitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Otolaryngology.
Does Dr. Mary J. Xu participate in research or clinical trials?
Yes. Dr. Mary J. Xu has published 54 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Dr. Mary J. Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mary J. Xu accept my insurance?
Dr. Mary J. Xu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-885-7528 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Dry MouthDr. Xu isExperienced. Learn about Dry Mouth.
- GastrostomyDr. Xu isExperienced. Learn about Gastrostomy.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Hearing LossDr. Xu isExperienced. Learn about Hearing Loss.
- Nasopharyngeal CarcinomaDr. Xu isExperienced. Learn about Nasopharyngeal Carcinoma.
- Oral Squamous Cell CarcinomaDr. Xu isExperienced. Learn about Oral Squamous Cell Carcinoma.